Levetiracetant is equally effective as L-dopa in treating the complaints of restless legs syndrome

被引：0
|
作者：
Remi, J. [1 ]
Simakov, A. [1 ]
Noachtar, S. [1 ]
机构：
[1] Univ Munich, Munich, Germany
来源：
JOURNAL OF NEUROLOGY | 2007年 / 254卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：197 / 197
页数：1
相关论文
共 50 条
  • [1] L-DOPA IN UREMIC PATIENTS WITH THE RESTLESS LEGS SYNDROME
    SANDYK, R
    BERNICK, C
    LEE, SM
    STERN, LZ
    IACONO, RP
    BAMFORD, CR
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 1987, 35 (3-4) : 233 - 235
  • [2] Restless legs syndrome: Treatment with L-dopa or L-dopa slow release preparations
    Schwarz, J
    Trenkwalder, C
    AKTUELLE NEUROLOGIE, 1996, 23 (01) : 26 - 29
  • [3] Validation of the "L-DOPA test" for diagnosis of restless legs syndrome
    Stiasny-Kolster, Karin
    Kohnen, Ralf
    Moeller, Jens Carsten
    Trenkwalder, Claudia
    Oertel, Wolfgang H.
    MOVEMENT DISORDERS, 2006, 21 (09) : 1333 - 1339
  • [4] THE EFFECTS OF L-DOPA IN UREMIC PATIENTS WITH RESTLESS LEGS SYNDROME
    BERNICK, C
    LEE, SM
    SANDYK, R
    STERN, LZ
    NEUROLOGY, 1986, 36 (04) : 162 - 162
  • [5] RESTLESS LEGS SYNDROME AND PERIODIC MOVEMENTS IN SLEEP - PHYSIOPATHOLOGY AND TREATMENT WITH L-DOPA
    MONTPLAISIR, J
    GODBOUT, R
    POIRIER, G
    BEDARD, MA
    CLINICAL NEUROPHARMACOLOGY, 1986, 9 (05) : 456 - 463
  • [6] BENEFICIAL-EFFECTS OF L-DOPA IN DIALYSIS PATIENTS WITH RESTLESS LEGS SYNDROME
    LEE, SM
    BERNICK, C
    SANDYK, R
    STERN, LZ
    KIDNEY INTERNATIONAL, 1986, 29 (01) : 195 - 195
  • [7] EFFECTIVE L-DOPA THERAPY OF UREMIC AND IDIOPATHIC RESTLESS LEGS SYNDROME - A DOUBLE-BLIND CROSSOVER TRIAL
    TRENKWALDER, C
    STIASNY, K
    POLLMACHER, T
    WETTER, T
    SCHWARZ, J
    KOHNEN, R
    KAZENWADEL, J
    RAMM, S
    OERTEL, WH
    NEUROLOGY, 1994, 44 (04) : A217 - A217
  • [8] Effects of L-DOPA on dim light melatonin onset in patients with restless legs syndrome
    Garcia-Borreguero, D
    Larrosa, O
    SLEEP, 2003, 26 : A340 - A340
  • [9] Circadian variation in neuroendocrine response to L-dopa in patients with 14 restless legs syndrome
    Garcia-Borreguero, D
    Larrosa, O
    Granizo, JJ
    de la Llave, Y
    Hening, WA
    SLEEP, 2004, 27 (04) : 669 - 673
  • [10] L-DOPA THERAPY OF UREMIC AND IDIOPATHIC RESTLESS LEGS SYNDROME - A DOUBLE-BLIND, CROSSOVER TRIAL
    TRENKWALDER, C
    STIASNY, K
    POLLMACHER, T
    WETTER, T
    SCHWARZ, J
    KOHNEN, R
    KAZENWADEL, J
    KRUGER, HP
    RAMM, S
    KUNZEL, M
    OERTEL, WH
    SLEEP, 1995, 18 (08): : 681 - 688
12345